Education
About Us
Working with TipRanks
Follow Us
Health Catalyst (HCAT)
NASDAQ:HCAT
HCAT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.76 - $9.24
Previous CloseN/A
Volume315.36K
Average Volume (3M)886.88K
Market Cap
$319.46M
Enterprise Value$451.27M
Total Cash (Recent Filing)$28.43M
Total Debt (Recent Filing)$26.91M
Price to Earnings (P/E)―
Beta1.73
Next Earnings
May 13, 2025EPS Estimate
<0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.15
Shares Outstanding70,210,650
10 Day Avg. Volume628,251
30 Day Avg. Volume886,885
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.01
Price to Cash Flow (P/CF)-22.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.41
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit3.42
Enterprise Value/Ebitda-13.95
Forecast
1Y Price Target
$8.54Price Target Upside87.69% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13
---
Bulls Say, Bears Say
Bulls Say
Client Acquisition ConfidenceHCAT plans to add 40 net platform clients in 2025, with 10 clients coming in the first quarter, suggesting confidence in client acquisition.
Technology Platform GrowthThe company's next-gen Ignite data and analytics platform is driving a reacceleration in high-margin technology sales at the organization, as evidenced by record new platform client additions.
Bears Say
Dilution ConcernsInvestors reacted negatively to the 10% dilution associated with the acquisition of Upfront Healthcare, as the deal was financed with a mix of cash and stock.
Earnings Guidance Concerns1Q'25 guidance was well below expectations, raising questions on the believability of the full year 2025 guided revenue and adj-EBITDA ramp.
---
Ownership Overview
11.67% Insiders
22.39% Mutual Funds
30.85% Other Institutional Investors
24.20% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
HCAT FAQ
What was Health Catalyst’s price range in the past 12 months?
Health Catalyst lowest stock price was $3.76 and its highest was $9.24 in the past 12 months.
What is Health Catalyst’s market cap?
Health Catalyst’s market cap is $319.46M.
When is Health Catalyst’s upcoming earnings report date?
Health Catalyst’s upcoming earnings report date is May 13, 2025 which is in 43 days.
How were Health Catalyst’s earnings last quarter?
Health Catalyst released its earnings results on Feb 26, 2025. The company reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.073 by -$0.033.
Is Health Catalyst overvalued?
According to Wall Street analysts Health Catalyst’s price is currently Undervalued.
Does Health Catalyst pay dividends?
Health Catalyst does not currently pay dividends.
What is Health Catalyst’s EPS estimate?
Health Catalyst’s EPS estimate is <0.01.
How many shares outstanding does Health Catalyst have?
Health Catalyst has 70,210,650 shares outstanding.
What happened to Health Catalyst’s price movement after its last earnings report?
Health Catalyst reported an EPS of $0.04 in its last earnings report, missing expectations of $0.073. Following the earnings report the stock price went down -11.134%.
Which hedge fund is a major shareholder of Health Catalyst?
Currently, no hedge funds are holding shares in HCAT
---
Health Catalyst Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$8.54 (87.69% Upside)
$8.54 (87.69% Upside)
Blogger Sentiment
Bullish
HCAT Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 441.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 3.4%
Last 30 Days ▲ 3.5%
Last 30 Days ▲ 3.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-39.57%
12-Months-Change
Fundamentals
Return on Equity
-18.99%
Trailing 12-Months
Asset Growth
22.39%
Trailing 12-Months
Company Description
Health Catalyst
Health Catalyst (HCAT) is a leading provider of data and analytics technology and services, primarily catering to the healthcare sector. The company offers a comprehensive suite of software applications designed to help healthcare organizations improve clinical, financial, and operational outcomes. Health Catalyst's core products include a data platform, analytics applications, and professional services that enable data-driven decision-making and enhance performance across healthcare networks.
---
HCAT Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected solid revenue growth and successful client acquisitions, particularly with the new Ignite platform. However, challenges included lower professional services revenue and temporarily reduced gross margins due to ongoing migrations and headcount adjustments.Read More>---
HCAT Stock 12 Month Forecast
Average Price Target
$8.54
▲(87.69% Upside)
Technical Analysis
Best Analysts Covering HCAT
1 Year
1 Year Success Rate
6/18 ratings generated profit
1 Year Average Return
-24.29%
reiterated a buy rating last month
Copying David Larsen's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -24.29% per trade.
---